- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Endotoxin removal by polymyxin B: is it a question of dose or duration or both? ; volume:23 ; number:1 ; day:4 ; month:9 ; year:2019 ; pages:1-2 ; date:12.2019
Critical care ; 23, Heft 1 (4.9.2019), 1-2, 12.2019
- Creator
-
Honore, Patrick M.
Bels, David De
Barreto Gutierrez, Leonel
Redant, Sebastien
Gallerani, Andrea
Boer, Willem
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-019-2584-5
- URN
-
urn:nbn:de:101:1-2020012020270702124248
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Honore, Patrick M.
- Bels, David De
- Barreto Gutierrez, Leonel
- Redant, Sebastien
- Gallerani, Andrea
- Boer, Willem
- SpringerLink (Online service)
Other Objects (12)
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Normal saline as resuscitation fluid in critically ill patients: not dead yet!